Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Keep in mind, the CTAD presentation will be at 7:30 EST!
4:30 west coast time.
Or now labeled “ Neurodegenerative diseases”
Basket trial perhaps??
Schizophrenia and Alzheimers have been omitted from the pipeline chart for A3-71 on Anavex’s webpage.
Intentional or a mistake?
https://www.anavex.com/therapeutic-candidates
Found the video of Dr Hargerman
Does anyone remember Dr Hagerman mentioning something about DOD funding for an Anavex fragile x or another CNS trial a while back?
Agreed, however if he is buddies with Adam F, it would look bad if be bashed a stock that Cramer “likes “
With Cramer warming up to AVXL, perhaps the expected hit pieces from AF will be scaled back? Or just wishful thinking.
They are both shady.
http://drive.google.com/file/d/1ezfl9YHq55vj61CxjZH5mGxIXJ2k_1xy/view?usp=sharing
Thanks for the video ckent!
It’s time for ANAVEX to get its own IR department
———————————————
AVXL’s IR person, Andrew Barwicki, is also
employed as the IR person for SAVA
http://barwicki.com/
http://barwicki.com/images/SAVA_July_2021.pdf
AVXL’s IR person, Andrew Barwicki, is also
employed as the IR person for SAVA
http://barwicki.com/
http://barwicki.com/images/SAVA_July_2021.pdf
Another small sign that the AD TLR is good.
If the TLR was not as good as expected and the stock tanked, TGD would probably save these types of PR’s to try to prop up the PPS .
Actually, he is presenting on November 30 at 1:45, just one day before the CTAD presentation.
Looks like TGD will be catching the red-eye BOS-SFO on the 30th!
https://neurodevelopmental-drug-development.com/program/day-two/
Thanks Boi, I would like to hear your opinion on the delay to recruit 16 additional girls.
I don’t mean to come off as negative, but doesn’t over one year seem strange.
All eyes are obviously on AD right now, but RETT will still likely be our first approval and revenue generator.
Does anyone know the number of additional RETT trial participants that was requested by the FDA for the Excellence trial?
I find it odd that it is taking this long to recruit the handful of additional girls even with Dr Kaufman, one of the leading KOLs
In the field.
The Rett advocate groups are seemingly supportive of Anavex.
I understand the whole UK Covid vaccination delay, but this extended delay has become excessive.
Maybe Anavex is waiting until after the AD results are announced to up date the other six catalysts due next month.
Is missing one endpoint still considered to be a material event?
3 but I would prefer 6plus
“Given the UK's much touted indepence of the EU and need to prove the benefits, perhaps the most likely to make a move on great P2b/3 results?”
I also remember reading a while back that the Australian TGA
Rarely breaks for the FDA on drug approvals.
What are your thoughts about that?
Thanks Inv! Great info.
Does anyone have a breakdown of the AD 2b/3 trial patients from various countries?
I believe Australia had around 60% of the participants .
So you are suggesting another 3-4 years for two p3 trials to be run?
Something to think about. Post from Papatrick on ST-
“Is it possible that Missling
waits to see the real value of 2-73
before launching Fragile x or PK
trials? If it fails at AD in a few days or
weeks, he would rather push 3-71
asap at ph2 for all diseases targetted
(including MS, SLA, AD, FTD, PK) and
leave 2-73 only for Rett and PDD? If it
succeed, then he will launch ph3
trials with 2-73 at least for PDD, PK
and Fragile X in addition to file for
NDA. 3-71 will take the rest plus AD
too.“
Repost from Mighty _Kurtz a couple months ago-
“I've had my ears to the
ground in Melbourne for a while.
I've heard anecdotal evidence
from the family of a number of AD
Phase Ill trial participants
attesting to the wonders of
ANAVEX®2-73.
Take for example the case of
Dave* who, after 11 months on
ANAVEX®2-73, has regained the
ability to score in tennis - a skill
that has eluded him ever since
being diagnosed with AD by his
geriatrician, and which was the
main reason why he had
withdrawn from the sport.
Dave is delighted to be playing
social tennis again.”
If the REDDIT crowd jumps in, this could be explosive fast!
From REDDIT this morning-
AVXL Massive Potential
anavex
LIFE SCIENCES Corp.
As of this post AVXL (Anavex) is trading at about $12.50
(18% jump today) and likely run up to at least $20 to $30 by
Dec 1 with upcoming CTAD conference late breaking oral
presentation.
The AD space has been a very active space for making tons
of money. See SAVA Cassava Sciences. SAVA has had a run
up to over $100 per share on anticipation of results putting it
at over a $5billion market cap. SAVA is till 12 to 36 months
out with trial results. BIlB added about $20Billion in market
cap recently with announced trial results for AD treatment.
You can do your own research on the space, but the set up
with AVXL is pretty clear. The company has had significantly
positive trial results in AD, Parkinsons, and Rett ...all using
the same drug platform. The safety profile has been clean.
This is from 5 plus years of various trial results.well baked.
Now we are at a major inflection point for AVXL. Prior to
today, we all have been waiting for various trial results that
have been promised for Q4 of this year. Now we have an
announcement from AVXL
https://finance.yahoo.com/news/anavex-life-sciences-
attend and participate in the AVXL presentation. Put your
logic hat on…AVXL would not have submitted for late
breaking oral presentation AND make a press release about it
over the last few days to present negative news. In fact if
there was negative news, SEC regs require near immediate
disclosure. Getting on the "late breaking news" agenda at the
conference requires something newsworthy and of scientific
significance. So clearly it looks like solid positive news..the
questions is how positive. If we have great trial results (which
all indications suggest that's were we are headed) we are
looking at a 10 to 30x jump in the stock
For sake of discussion…..if AVXL were to run up to the 5Billion
market cap similar to SAVA, we have a $60 stock…that's just
speculation on the results and this price run up could happen
by Dec 1. If we hit the holy grail and have a clear path to
approval (very possible) we are looking at a $20 Billion plus
market cap.or $250 + per share. In short there appears to
be a significant de risked run up in price scenario between
now and Dec 1 (CTAD presentation)
My likely guess is that we hit $20 to $40 + before CTAD. With
good results presented we see $100 plus after the
presentation. A good strategy...buy a strong position now..
enjoy the likely run up between now and Dec 1…along the
way soften your position so you are playing with house
money for presentation results. $10k could realistically turn
into $300k over the next 8 weeks.
From REDDIT this morning-
AVXL Massive Potential
anavex
LIFE SCIENCES Corp.
As of this post AVXL (Anavex) is trading at about $12.50
(18% jump today) and likely run up to at least $20 to $30 by
Dec 1 with upcoming CTAD conference late breaking oral
presentation.
The AD space has been a very active space for making tons
of money. See SAVA Cassava Sciences. SAVA has had a run
up to over $100 per share on anticipation of results putting it
at over a $5billion market cap. SAVA is till 12 to 36 months
out with trial results. BIlB added about $20Billion in market
cap recently with announced trial results for AD treatment.
You can do your own research on the space, but the set up
with AVXL is pretty clear. The company has had significantly
positive trial results in AD, Parkinsons, and Rett ...all using
the same drug platform. The safety profile has been clean.
This is from 5 plus years of various trial results.well baked.
Now we are at a major inflection point for AVXL. Prior to
today, we all have been waiting for various trial results that
have been promised for Q4 of this year. Now we have an
announcement from AVXL
https://finance.yahoo.com/news/anavex-life-sciences-
attend and participate in the AVXL presentation. Put your
logic hat on…AVXL would not have submitted for late
breaking oral presentation AND make a press release about it
over the last few days to present negative news. In fact if
there was negative news, SEC regs require near immediate
disclosure. Getting on the "late breaking news" agenda at the
conference requires something newsworthy and of scientific
significance. So clearly it looks like solid positive news..the
questions is how positive. If we have great trial results (which
all indications suggest that's were we are headed) we are
looking at a 10 to 30x jump in the stock
For sake of discussion…..if AVXL were to run up to the 5Billion
market cap similar to SAVA, we have a $60 stock…that's just
speculation on the results and this price run up could happen
by Dec 1. If we hit the holy grail and have a clear path to
approval (very possible) we are looking at a $20 Billion plus
market cap.or $250 + per share. In short there appears to
be a significant de risked run up in price scenario between
now and Dec 1 (CTAD presentation)
My likely guess is that we hit $20 to $40 + before CTAD. With
good results presented we see $100 plus after the
presentation. A good strategy...buy a strong position now..
enjoy the likely run up between now and Dec 1…along the
way soften your position so you are playing with house
money for presentation results. $10k could realistically turn
into $300k over the next 8 weeks.
Will the TLD data be embargoed until the
Dec 1st presentation ?
Thanks TTT? I don’t that they want to report poor results!!
Dr Missing said to expect TLD in FALL. We are three weeks into FALL!
Did anyone here, that has been invested more than a few months, really expect TLD to be announced on September 22?
NEW VIDEO-Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
I’m still waiting to hear why he claimed that the database was still not locked after three and a half months.
The XBI being up 3 percent doesn’t hurt either!
$11 today?
WGT!
George, no answer to your claim that the database is still not locked?
George, can you tell where you see that database is still not locked?
It’s kind of a big deal.
December 20th?
Looks like RETT will be first up if what George said is true!
On bright side, the voucher issue should be solved!
So we are looking at a 3-4 month delay?? WTF!
“The database has not been locked yet “
georgejjl posted on ST-
“ it has been 3 months since
the last participant last visit but
the database has NOT been
locked vet. Does that mean that data analysis hasn’t even begun??